166 related articles for article (PubMed ID: 1683561)
21. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
22. Characterization of cholecystokinin receptors on the sphincter of Oddi.
Cox KL; von Schrenck T; Moran TH; Gardner JD; Jensen RT
Am J Physiol; 1990 Nov; 259(5 Pt 1):G873-81. PubMed ID: 2240227
[TBL] [Abstract][Full Text] [Related]
23. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
24. The binding of bombesin and somatostatin and their analogs to human colon cancers.
Radulovic SS; Milovanovic SR; Cai RZ; Schally AV
Proc Soc Exp Biol Med; 1992 Jul; 200(3):394-401. PubMed ID: 1352046
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of down-regulation in streptozotocin diabetes.
Srikant CB; Patel YC
J Biol Chem; 1986 Jun; 261(17):7690-6. PubMed ID: 2872218
[TBL] [Abstract][Full Text] [Related]
26. Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters.
Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
Carcinogenesis; 1996 Oct; 17(10):2171-5. PubMed ID: 8895485
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
28. Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice.
Alexander RW; Upp JR; Poston GJ; Townsend CM; Singh P; Thompson JC
Pancreas; 1988; 3(3):297-302. PubMed ID: 2838842
[TBL] [Abstract][Full Text] [Related]
29. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.
Blevins GT; van de Westerlo EM; Williams JA
Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749
[TBL] [Abstract][Full Text] [Related]
30. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
Fekete M; Zalatnai A; Schally AV
Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
[TBL] [Abstract][Full Text] [Related]
31. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C
Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
34. Characterization of gastrin receptors on guinea pig pancreatic acini.
Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
[TBL] [Abstract][Full Text] [Related]
35. Characterization of cholecystokinin receptors on guinea pig gastric chief cell membranes.
Matozaki T; Sakamoto C; Nagao M; Nishisaki H; Konda Y; Nakano O; Matsuda K; Wada K; Suzuki T; Kasuga M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1055-63. PubMed ID: 1996975
[TBL] [Abstract][Full Text] [Related]
36. Binding of cholecystokinin and somatostatin to isolated porcine gastric mucosal cells and effects on aminopyrine uptake.
Sjödin L; Englund LJ; Mårdh S
Acta Physiol Scand; 1990 Mar; 138(3):369-76. PubMed ID: 1970214
[TBL] [Abstract][Full Text] [Related]
37. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
[TBL] [Abstract][Full Text] [Related]
40. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
Kimura N; Hayafuji C; Konagaya H; Takahashi K
Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
